Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer.

Author: Jie CHANG ¹ ; Ruirui YANG ² ; Lifan CHEN ² ; Zisheng FAN ¹ ; Jingyi ZHOU ¹ ; Hao GUO ² ; Yinghui ZHANG ² ; Yadan LIU ¹ ; Guizhen ZHOU ¹ ; Keke ZHANG ¹ ; Kaixian CHEN ² ; Hualiang JIANG ² ; Mingyue ZHENG ² ; Sulin ZHANG ²
Author Information

1. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
2. Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Publication Type:Journal Article
Keywords: ADP-ribosylation factor 1; Breast cancer; Demethylzeylasteral; Virtual screening
From: Acta Pharmaceutica Sinica B 2022;12(5):2619-2622
CountryChina
Language:English
Abstract: Image 1.